Canadian firm's implant controls glucose in diabetic pigs

07/12/2010 | Reuters

Diabetic pigs treated with Sernova's Cell Pouch System showed long-term normal glucose levels without experiencing adverse events, according to preclinical trials. The implantable device uses insulin-producing tissues, or islets, derived from the pancreas of the animals to enable the therapeutic cells to thrive and function in a natural environment.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN